Overview
Frontotemporal Dementia PBMC
Frontotemporal Dementia PBMC is collected from IRB-consented donors diagnosed with clinically confirmed Frontotemporal Dementia (FTD). These peripheral blood mononuclear cell (PBMC) samples are ideal for profiling peripheral immune cells involved in neuroinflammation and neurodegeneration. PBMCs from FTD donors are valuable for studying immune dysregulation, transcriptomics, and neurodegenerative disease mechanisms.
Product Features
- Cryopreserved, clinically verified FTD PBMC samples
- Cryopreserved to ensure stability and long-term storage
- Research Use Only (RUO)
Donor Metadata
- Clinically confirmed FTD diagnosis
- Donor demographics: age, sex assigned at birth, ethnicity
- Medical and treatment history available when applicable
Applications
- Profiling peripheral immune cells involved in neuroinflammation and neurodegeneration
- Biomarker discovery and validation
- Transcriptomic, proteomic, or functional studies
- Custom assay development and disease modeling
Compliance and Quality
- IRB-approved collection and electronic informed consent
- HIPAA-compliant donor data handling
Ordering and Customization
Frontotemporal Dementia PBMC is available in standard and custom volumes. Contact [email protected] for international requests or documentation needs.
Protocols and Documentation
Publications
Data and Testing
Data and Testing with Every Sample
- Donor demographics
- Donor-reported allergies
- Donor-reported infectious disease history
Compliance & Quality Assured
For quality and compliance related information, please visit Sanguine quality and compliance page.
For privacy related information, please visit Sanguine privacy policy page.